Sandoz Czech Republic’s Post

Excellent Jefferies Healthcare Conference this year. A couple of take aways: * Access to #capital remains a challenge across sectors, especially for early-stage companies. But those well-positioned for growth continue to find ways *Actors in the #healthcare space explore multiple strategic #transactions, indicating an outlook for a variety of deal types in the near future

Bausch + Lomb Sale Could Unlock Trapped Value: Credit Outlook A potential sale of Bausch + Lomb presents a way forward for the company to unlock embedded value. Prior to a report about a possible process underway, Bausch + Lomb traded at an enterprise value-to-Ebitda multiple around 11x, while peers Cooper and Alcon were valued at 20x. Cutting ties to Bausch Health should drive Bausch + Lomb's valuation closer to peers. Following its partial separation from Bausch Health, Bausch + Lomb's investment in strategic assets topped out leverage around 5x and brought Ebitda to almost $900 million. Using an illustrative 15x EV/EBITDA valuation, Bausch + Lomb would be valued around $13 billion. Check out the full note on the Terminal here: https://lnkd.in/ezb6Vjjm #bloombergintelligence #highyieldbonds

Exciting News: Introducing ICR Healthcare!   We’re thrilled to announce the launch of ICR Healthcare, unifying ICR Westwicke (US) and ICR Consilium (EU) under one powerful global brand. This integration creates a worldwide leader in healthcare strategic communications, investor relations, and capital markets advisory with: 👥80+ team members 🌎200+ clients across 20+ countries 🏥Experience across all healthcare sub-sectors 🤝Comprehensive support from startup to mature public company   This milestone brings together our deep sector expertise, extensive investor networks, and comprehensive communications capabilities under one unified banner – offering truly integrated global reach and expertise.   Whether you’re an emerging biotech or a multinational healthcare leader, ICR Healthcare provides seamless access to expanded services and strategic opportunities across North America and Europe.   Learn more about how we can support your company’s growth journey: https://lnkd.in/eDKsG_c2   #ICRHealthcare #HealthcarePR #GlobalCommunications #InvestorRelations

Exciting News: Introducing ICR Healthcare! We’re thrilled to announce the launch of ICR Healthcare, unifying ICR Westwicke (US) and ICR Consilium (EU) under one powerful global brand. This integration creates a worldwide leader in healthcare strategic communications, investor relations, and capital markets advisory with: 👥 80+ team members 🌎 200+ clients across 20+ countries 🏥 Experience across all healthcare sub-sectors 🤝 Comprehensive support from startup to mature public company This milestone brings together our deep sector expertise, extensive investor networks, and comprehensive communications capabilities under one unified banner – offering truly integrated global reach and expertise. Whether you’re an emerging biotech or a multinational healthcare leader, ICR Healthcare provides seamless access to expanded services and strategic opportunities across North America and Europe. Learn more about how we can support your company’s growth journey: https://lnkd.in/eDKsG_c2 #ICRHealthcare #HealthcarePR #GlobalCommunications #InvestorRelations

Yesterday, I had the pleasure of representing Roche Polska at the Prix Galien Polska Forum 2024 in Warsaw. During the "Med-Tech CEO" panel, we explored the world of innovative medical and diagnostic technologies and their impact on patients' lives. 📢 Key takeaways: Science and tech are advancing rapidly, and at Roche, we're leading the change with home-based diagnostic and treatment services. These innovations help reduce hospital visits and make healthcare more accessible. Our Accu-Chek® Guide system and mySugr app are just 2 examples of how we're making it easier for patients to manage their health from home.  📍 At Roche, we remain dedicated to advancing healthcare and making a real difference in patients' lives. We are uniquely positioned to lead the way in personalized healthcare by combining our strengths in pharmaceuticals, data management and diagnostics. Our mission is to provide the right treatment for the right patient at the right time and for the right value. #Prevent, #Stop, #Cure.  Big thanks to the organizers for the invite and to everyone involved in the discussion.  Anna Sadowska-Segit Beata Karasińska, Sebastian Hutek, Renata Dąbrowska, MBA, Kamil Renyi, Marcin Morag, Jacek Byrt and to Katarzyna Raczyńska and Adam Krenke #GalienForum #MedTech #HealthInnovation #Roche #PatientCare

We are proud to highlight the participation of 2CA-Braga at the Clinical Trials Summit 2024, held on November 28-29 in Barcelona. Representing the organization, Eduarda Correia, Clinical Research Assistant, delivered a compelling presentation on “Empowering Academic CROs: Building Resilience for Upcoming Challenges.” Her insights, followed by a thought-provoking discussion, explored innovative strategies to enhance resilience in academic CROs—an essential step in meeting the evolving demands of clinical research. The summit was a vibrant platform for meaningful discussions, knowledge sharing, and collaboration, with the shared goal of shaping the future of clinical trials. ✨ Together, we are driving the transformation of clinical research! #ClinicalTrialsSummit #ClinicalResearch #AcademicCROs #ClinicalData #HealthcareInnovation #CROInnovation #ClinicalTrialSolution

“One single company cannot solve a problem. Whether it being at a digital endpoint or new modalities, we have to work together across the industry.” Listen to industry leaders Adama Ibrahim, EMBA, Dr Susie Stephens and Thomas Lonborg-Jensen at Novo Nordisk, Angela Radcliffe at Bristol Myers Squibb, Kailash Swarn at Accenture, and Dr Ingrid Sofie Harbo at Lundbeck discuss end-to-end digital transformation! Watch the full video linked below. 📽️ https://lnkd.in/gJBRHuqM 🔗 Learn more about Mobile in Clinical Trials 2024, the leading conference for patient technologies in research: https://lnkd.in/ggv8w76s #digitalhealthtech #digitalinnovation #mobiletechnology #clinicalresearch

A Global Approach to DEI in Clinical Trials Robina Weermeijer Boehringer Ingelheim As the world is becoming more and more diverse there is a big need to consider a wide audience when conducting clinical trials. In this presentation, you'll get insights into why it's important to look at diversity, equity, and inclusion on a global level and which efforts are being made by Boehringer Ingelheim in this space through collaboration with diverse stakeholders. https://bit.ly/3jRNCin #ScopeSummit #ClinicalTrials

Empowering Healthcare Access in Mexico & LatAm Rogerio C. Peso Peso, Head of Mexico & CCS at Viatris, shares insights on how the company is attempting to transform healthcare across Mexico and Latin America. From leveraging strategic partnerships and tailoring solutions to local market needs, to championing access and affordability, Pesooutlines Viatris’ mission to bridge healthcare gaps with both innovative and generic medicines. He also discusses the importance of balancing global strategies with local execution, the significance of Mexico for Viatris’ growth, and his leadership approach that prioritizes diversity, empowerment, and adaptability. Get the full picture at https://lnkd.in/dWU_vY7W

Calling all clinical trial professionals! Madeline Geday, Head of Patient Engagement & Clinical Strategy/Decentralized Clinical Trials at Astellas Pharma US, is taking the stage at the Data Driven, Hybrid & Full Decentralized Clinical Trials, an event you won't want to miss this April in Philadelphia! Her session, "Innovative Technologies for the Assessment of Innovative Products – Ensuring System Flexibility," dives deep into: ✅ The impact of cutting-edge technologies on clinical trial infrastructure and execution, specifically in full and hybrid DCTs. ✅ A real-world case study to illustrate these concepts in action. ✅ Crucial considerations for ensuring your chosen technology seamlessly integrates with patient needs, data integrity, logistics, and cost-effectiveness Don't miss this opportunity to stay ahead of the curve in the ever-evolving world of clinical trials! ⚠ Limited FREE seats are still available!* Secure yours before they're gone: https://lnkd.in/ePYyVzWb #DCT #clinicaltrials #clinicalinnovation #patientcentricity #datadriventrials